Pulmatrix

0 followers

Specialty biotech developing the next generation of inhaled therapies for such conditions as #cysticfibrosis #COPD & idiopathic pulmonary fibrosis.

Industries

Employees

11-50

Links


Org chart

Peter Ludlum
Interim Chief Executive Officer
Margaret Wasilewski
Chief Medical Officer
Valielza O’Keefe
Research Associate

Board & advisors

William J. Calhoun
Chair, Clinical Advisory Board
Chris Cabell
Director
Mark Iwicki
Director
Rick Batycky
Director
Peter Wark
Advisor